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Background: The inability of current vaccines to provide effective protection against porcine reproductive and
respiratory syndrome virus (PRRSV) infection is not fully understood. One of the reasons might be the presence
of anti-idiotypic antibodies (Ab2s) to the envelope glycoprotein GP5 induced by PRRSV infection since our previous
studies demonstrated the presence of auto-Ab2s (aAb2s) in pigs infected with PRRSV. To test this hypothesis,
PRRSV negative piglets were injected with a monoclonal Ab2 (Mab2-5G2) and aAb2s that are specific for anti-GP5
antibody, vaccinated with the attenuated PRRSV vaccine CH-1R and then challenged with the highly pathogenic
PRRSV HuN4 strain. The animals were evaluated for clinical signs, pathological changes of the thymus and lungs,
viremia, levels of serum antibodies and cytokines.
Results: The piglets injected with Mab2-5G2 or aAb2, and who received the attenuated PRRSV vaccine CH-1R
before challenge, produced high levels of anti-N antibodies, IL-2 and IL-4, but low levels of neutralizing antibodies.
After PRRSV HuN4 challenge, the animals showed obvious clinical signs, including lung lesions, severe thymus
atrophy and decreased production of IL-4 and higher level of viremia.
Conclusion: When anti-GP5 Ab2s are present, the use of attenuated PRRSV vaccine CH-1R against HP-PRRSV
infection is not recommended. It can result in poor health status with pneumonia and thymus atrophy.
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Porcine reproductive and respiratory syndrome (PRRS)
has emerged as one of the most important swine diseases
worldwide since its appearance in the late 1980s. PRRS
virus (PRRSV), the causative agent of PRRS, is an envel-
oped RNA virus belonging to the family Arteriviridae. The
virus genome, like other members of the family [1], con-
tains nine open reading frames [2-4]. PRRSV infects mac-
rophages, damages the immune system and causes severe
host immune response disorders. This results in pro-
longed viremia, transiently diminishing T-cell immunity
[5-7] and delayed or low neutralizing antibody response* Correspondence: zhouem@nwsuaf.edu.cn
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unless otherwise stated.against the envelope glycoprotein 5 (GP5) and the matrix
(M) protein [8,9].
The immune network theory proposed by Jerne [10]
suggests that idiotype (Id) and anti-Id interactions control
the immune response to an antigen via either positive
(enhancing) or negative (suppressing) feedback mecha-
nisms [11-14]. Our previous studies demonstrated that
PRRSV infection induced the production of auto-anti-
Id (aAb2s) specific for antibodies to the GP5 and M
proteins [15,16]. The pigs produced aAb2s during the
early stage of infection (35 days post infection) cleared
the virus, whereas those pigs who had aAb2s at the
later stage of infection (77 days post infection) became
virus carriers. These results suggested the presence of
aAb2s specific for anti-GP5 or anti-M antibodies may
interfere with the immune responses against PRRSV
infection.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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PRRSV vaccines cannot provide sustainable disease con-
trol [17]. The efficacy of PRRSV vaccination against
PRRSV infection may be related to the cellular immune
responses induced by vaccination [18-20]. In addition,
the live attenuated vaccines have protective value against
PRRS clinical disorders, but cannot prevent the disease
or shorten persistent infection in individual pigs, result-
ing in long-term circulation of virus within swine herds
[21] and the potential to revert to virulence [22].
The inability of current vaccines to provide effective
protection against PRRSV infection is not fully under-
stood. We hypothesize one of the reasons for this is that
PRRSV infection induces the production of anti-Ids to
anti-GP5 and when these anti-Ids are present, they inter-
fere with the efficacy of the attenuated PRRSV vaccine
(CH-1R) to protect against highly pathogenic (HP)
PRRSV infection. To test this hypothesis, piglets free of
PRRSV were injected with either a monoclonal Ab2
(designated Mab2-5G2) [23] or aAb2s specific to anti-
GP5 antibody. Piglets then received CH-1R and were
challenged with the HP-PRRSV HuN4 strain. The results
showed that piglets who received Mab2-5G2 or aAb2s
and were vaccinated with CH-1R before HP-PRRSV in-
fection produced high levels of serum IL-2 and IL-4.
After infection, these animals showed obvious clinical
signs of wheezing, anhelation, severe lethargy, anorexia,
purulent secretion and emaciation. Additionally there
were signs of depletion of cortical thymocytes or severe
thymus atrophy with decreased production of IL-4, low
levels of neutralizing antibodies and a high level of
viremia at the early stage of infection. These results sug-
gested that Ab2s specific for anti-PRRSV GP5 antibody
interfere with the immune responses against the attenu-
ated PRRSV vaccine CH-1R. Further study is needed to
identify, at the molecular and cellular levels, the roles of
the idiotype network in PRRSV immunity.Table 1 Respiratory scores measured on different DPCs
DPCs Scores from
1 2 3
0 0 (6) 0 (6) 0 (6
3 1.43 ± 0.20 (6)a 1.67 ± 0.21 (6)a 0 (6
7 2.71 ± 0.29 (6)a 3.0 ± 0.37 (6)a 0.71 ± 0.2
10 3.25 ± 0.48 (6)a 3.5 ± 0.22 (6)a 0.50 ± 0.2
14 3.5 ± 0.29 (6)a 2.33 ± 0.21 (6)a 0 (6
21 1.33 ± 0.33 (2)2 1.67 ± 0.33 (3) 0 (3
28 0.67 ± 0.33 (2) 1.33 ± 0.33 (3) 0 (3
1Respiratory scores were given from 0 to 4: 0, normal; 1, tachypnea when stressed;
and dyspnea with labored, jerky breathing. Each number represents the mean scor
with ANOVA.
2The numbers in parentheses were the numbers of piglets measured on different D
16 DPC and 18 DPC, respectively.
a,bValues with different superscripts were significantly different (P < 0.05).Results
Clinical presentation
No piglets showed clinical signs before HP-PRRSV chal-
lenge, consistent with their disease free status. After the
challenge with HP-PRRSV, Group 1, 2 and 5 piglets
showed wheezing and anhelation from 3 to 14 DPC with
the average scores of 1.43 to 3.67 (Table 1). Severe leth-
argy, anorexia and emaciation were observed from 3 to 16
DPC and purulent secretion from the nose between 7 to
21 DPC. One piglet from Group 1 and one piglet from
Group 5 died naturally from PRRS at 16 DPC and 18
DPC, respectively. Group 3 and 4 piglets showed transient
anhelation from 7 to 11 DPC with average scores of 0.5 to
1.12 (Table 1) without other obvious clinical signs and pig-
lets in Group 6 had no clinical signs.
The average rectal temperature of Group 1 and 2 piglets
was similar, with the highest temperature of 41.5°C be-
tween 5 and 6 DPC (Figure 1). The temperature remained
above 40.0°C to the end of the experiment. The rectal
temperature of Group 3 and 4 piglets started to rise from
2 DPC and returned to normal from 12 DPC to the end of
the experiment. The rectal temperature of Group 5 piglets
remained above 40°C from 2 to 20 DPC and dropped
below 40.0°C from 21 DPC to the end of the experiment.
Group 6 piglets had a normal rectal temperature.
Visual and histological observations
Severe thymus atrophy was observed for Group 1, 2
and 5 piglets on 14 DPC (data not shown) and 28 DPC
(Figure 2A, 2B, 2E). One piglet from Group 1 and one
from Group 5 died naturally from PRRS on 16 DPC
and 18 DPC, respectively, accompanied with severe thy-
mus atrophy (data not shown). The thymus atrophy of
piglets infected with HP-PRRSV was similar to that ob-
served in the previously reported study [24]. Thymus atro-
phy of Group 3 (Figure 2C) and Group 4 (Figure 2D)
piglets was weaker than that of Group 1 and 2 piglets onsix groups of piglets1
4 5 6
) 0 (6) 0 (6) 0 (6)
)b 0 (6)b 1.60 ± 0.24 (6)a 0 (6)
9 (6)b 1.12 ± 0.31 (6)b 3.0 ± 0.32 (6)a 0 (6)
9 (6)b 0.83 ± 0.31 (6)b 3.33 ± 0.33 (6)a 0 (6)
)b 0.33 ± 0.22 (6)b 3.67 ± 0.33 (6)a 0 (6)
) 0 (3) 1.50 ± 0.50 (2)2 0 (6)
) 0 (3) 0.5 ± 0.5 (2) 0 (6)
2, tachypnea at rest; 3, tachypnea and dyspnea at rest; 4, severe tachypnea
es (±S.D.) generated from six groups of piglets on different DPCs and analyzed
PCs and one piglet from each of Group 1 and Group 5 died from PRRS on
Figure 1 Rectal temperature (°C) changes in piglets after
HP-PRRSV infection. Group 1 to 4 piglets were given Mab2-5G2,
aAb2s, 7H12 and normal swine IgG on 0 DPI, respectively, vaccinated
on 14 and 28 DPI and challenged with HP-PRRSV on 0 DPC. Group 5
piglets were challenged with HP-PRRSV only and Group 6 piglets
received PBS. Each point represents the mean (±S.D) generated from
all piglets in each group on each DPC.
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mal (Figure 2F).
Thymuses collected on 28 DPC from Group 1 piglets
showed typical depletion of cortical thymocytes accom-
panied by blurred boundaries between the thymus cor-
tex and medulla as indicated by histology (Figure 3A).
Similar microscopic lesions were seen in the thymuses
of Group 2 and 5 piglets (Figure 3B, 3E). Group 3, 4 and
6 piglets showed no microscopic lesions of the thymus
(Figure 3C, 3D, 3F). Interstitial pneumonia lesions were ob-
served in Group 1, 2 and 5 piglets on 28 DPC (Figure 3G,
3H, 3K). The lung tissues from Group 3 and 4 piglets
were widened slightly on 28 DPC (Figure 3I, 3J), and
that from Group 6 piglets were normal (Figure 3L).
Viremia
Viremia of piglets from Groups 1–5 was detected start-
ing on 3 DPC (Table 2). The amount of virus was signifi-
cantly higher in Group 1 and 2 piglets who received
Mab2-5G2 and aAb2s, respectively, than that in piglets
from other Groups. The highest amount of virus present
in the sera of Group 1 and 2 piglets was on 7 DPC with
a mean titer of 108.0 copies/ml and 108.4 copies/ml, re-
spectively, and this started to decline from 10 DPC but
remained detectable at 21 DPC. Viremia in Group 3 and
4 piglets peaked on 7 DPC with a mean titer of 106.2
copies/ml and 106.0 copies/ml, respectively, which were
significantly lower (P < 0.05) than that from Group 1 and
2 piglets, and became undetectable on 21 DPC. The
amount of virus in Group 5 piglets on 3 DPC was sig-
nificantly lower than that from Group 1and 2 piglets
and the highest amount of virus was detected at 10 DPCwith the mean titer of 108.2 copies/ml, which dropped to
107.2 copies/ml on 14 DPC. These values were signifi-
cantly higher (P < 0.05) than those from Group 3 and 4
piglets and remained detectable on 21 DPC similar to
values from Group 1 and 2 piglets (Table 2). No virus
was detected in Group 6 piglets.
Serum concentrations of cytokines
The concentrations of IFN-γ, IL-2, IL-4 and IL-10 were
determined for all serum samples (Figure 4). The serum
concentrations of IFN-γ for Group 1–4 and Group 6
piglets were about 45 pg/ml in average for all serum
samples, whereas the levels of IFN-γ from Group 5 pig-
lets started to rise on 3 DPC and increased significantly
(P < 0.05) on 10 DPC (131 pg/ml) (Figure 4A).
The mean serum IL-2 concentration from piglets in
Group 1 and 2 was about 540 pg/ml and 460 pg/ml on 14
DPI and 0 DPC (42DPI), respectively. These were signifi-
cantly higher (P < 0.05) than those obtained from the
other four Groups of piglets with an average of 245 pg/ml
for all samples (Figure 4B).
The level of IL-4 in sera from Group 1 and 2 piglets
peaked on 35 DPI or 0 DPC with the average of 200 pg/ml
and then declined to the base levels on 3 DPC (Figure 4C).
In contrast, the level of IL-4 in serum from Group 3 and 4
piglets started to rise on 3 DPC, peaked on 7 DPC with an
average of 220 pg/ml and then declined gradually. The IL-
4 concentrations from Group 5 piglets were less than
110 pg/ml for all serum samples.
For the levels of serum IL-10, Group 5 piglets showed
the increased levels of approximately 220 pg/ml on
7DPC, peaked with 374 pg/ml on 10 DPC and then de-
clined gradually, but remained more than 200 pg/ml to
21 DPC (Figure 4D). The IL-10 concentrations from all
serum samples of Group 1–4 and Group 6 piglets were
less than 130 pg/ml (Figure 4D).
Serum anti-PRRSV antibodies
Anti-PRRSV antibodies from all piglets were detected in
sequential serum samples collected from 0 DPI to 21
DPC. The results of anti-N antibodies measured by
IDEXX ELISA were shown in Figure 5A. Piglets in Groups
1 to 4 seroconverted as early as 35 DPI (21 days post vac-
cination) with an average S/P value of about 0.5 and rose
quickly after HP-PRRSV challenge. In contrast, piglets in
Group 5 seroconverted on 10 DPC with the average S/P
value of 1.0 and peaked on 14 DPC (S/P = 1.42). Group 6
piglets had no detectable anti-N antibodies.
As shown in Figure 5B, serum anti-GP2/GP5 anti-
bodies from Group 1 and 2 piglets were detected on 0
DPC with the IRPC value of ≥20 and gradually increased
to a peak on 21 DPC with the IRPC value of 130. Simi-
larly, piglets from Groups 3 and 4 also seroconverted on
0 DPC and gradually increased with the higher IRPC
Figure 2 Gross pathology of thymus on 28 DPC. Thymus of a piglet from Group 1 (A), Group 2 (B) and Group 5 (E) showed serious atrophy. Thymus
of a piglet from Group 3 (C) and Group 4 (D) showed slight atrophy and thymus of an age-matched control piglet from Group 6 (F) was normal.
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and reached a peak on 21 DPC with the IRPC value of
170. In contrast, Group 5 piglets seroconverted on 14
DPC with the IRPC value of 46 and peaked on 21 DPC
(IRPC = 97.51). Serum anti-GP2/GP5 antibodies in Group
6 piglets were negative.
Neutralizing antibodies
Serum neutralizing antibodies against HP-PRRSV HuN4
strain were detected using aVN assay. As shown in Table 3,
the neutralizing antibodies were detected in Group 1 and 2
piglets starting at 21 DPI with an average titer of 2.5 and
peaked by 21 DPC. Group 3 and 4 piglets did not produce
detectable neutralizing antibodies until 35 DPIs, and grad-
ually increased to the peak on 21 DPC. Neutralizing anti-
bodies from Group 5 piglets were detected from 14 DPC.
Discussion
This report describes that the presence of monoclonal
anti-Id (Mab2-5G2) [23] or aAb2s [16] specific for anti-GP5 antibody interfered with the PRRSV attenuated vac-
cine, CH-1R, against HP-PRRSV infection. The ability of
CH-1R to provide effective protection against a HP-
PRRSV infection has been demonstrated in our previous
study [24], in which, CH-1R immunization decreased
and increased the serum level of IL-10 and IL-4, respect-
ively, along with the increased animal’s health status.
The results indicated that administration of Mab2-5G2
or aAb2s, to reproduce what would occur in a pig if it had
been infected with PRRSV before vaccination, markedly
reduced the ability of CH-1R in providing subsequent pro-
tection against HP-PRRSV infection. The selected amount
of Mab2-5G2 or aAb2s was based on the measurement of
aAb2s from pig sera (data not shown) which represented
the amounts that would be generated if they were natur-
ally infected with PRRSV.
HP-PRRSV infection alone induced severe thymus at-
rophy as demonstrated in previous findings [24,25]. In
this study, piglets which received Mab2-5G2 or aAb2s
and vaccination, also showed severe thymus atrophy
Figure 3 Pathological examinations of the thymus and lung on 28 DPC. Thymus of a piglet from Group 1 (A), Group 2 (B), and Group 5 (E)
showed blurred boundaries between the thymus cortex and medulla. Thymus of a piglet from Group 3 (C), Group 4 (D) and Group 6 (F) showed no
microscopic lesions (magnification × 50). Lungs of a piglet from Group 1 (G), Group 2 (H) and Group 5 (K) showed interstitial pneumonia lesions, lungs
of a piglet from Group 3 (I) and Group 4 (J) showed mild interstitial pneumonia, and a Group 6 piglet (L) was normal (magnification × 200).
Table 2 Virus quantity in serum samples detected on different DPCs
DPCs Virus quantity from six groups of piglets1
1 2 3 4 5 6
0 0 (6) 0 (6) 0 (6) 0 (6) 0 (6) 0 (6)
3 7.3 ± 0.3 (6)a 7.9 ± 0.6 (6)a 5.5 ± 0.3 (6)b 5.3 ± 0.2 (6)b 5.8 ± 0.2 (6)b 0 (6)
7 8.0 ± 0.2 (6) a 8.4 ± 0.4 (6) a 6.2 ± 0.3 (6) b 6.0 ± 0.4 (6) b 7.5 ± 0.3 (6) a 0 (6)
10 7.1 ± 0.2 (6)a 7.5 ± 0.3 (6)a 6.0 ± 0.4 (6)b 5.8 ± 0.4 (6)b 8.2 ± 0.2 (6)a 0 (6)
14 6.0 ± 0.6 (6)a 6.4 ± 0.5 (6)a 4.8 ± 0.5 (6)b 5.0 ± 0.5 (6)b 7.2 ± 0.4 (6)a 0 (6)
21 2.7 ± 1.3 (2)2 3.0 ± 0.7 (2) 0 (3) 0 (3) 2.3 ± 2.3 (2)2 0 (3)
1Each number represents the mean virus copies/ml (log10) (±S.D.) generated from six groups of piglets on different DPCs and analyzed with ANOVA.
2Same as that in Table 1.
a, bValues with different superscripts were significantly different (P < 0.05).
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Figure 4 Serum levels of cytokines. Serum concentrations of IFN-γ (A), IL-2 (B), IL-4 (C) and IL-10 (D) were measured using the commercial
ELISA kits (Market Inc, USA). Each point represents the mean value (±S.D) generated from six groups of piglets on different DPIs or DPCs.
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dicated that presence of Mab2-5G2 or aAb2s prevents
the efficacy of the CH-1R against HP-PRRSV-induced
thymus atrophy attributable to the thymocytes apoptosis
[25]. PRRSV infection induces cell apoptosis and this is
related to the activity of the GP5 protein [26]. Since
Mab2-5G2 and aAb2s were specific for anti-GP5 anti-
bodies, they may act in concert with GP5 protein to in-
duce apoptosis in thymocytes.
Swine possess the full repertoire of innate and adaptive
immune responses to viral pathogens, but the response to
PRRSV deviates from this model [27]. In general, Th1 re-
sponses are associated with IFN-γ and IL-2 production,
which are correlated with the induction of cell-mediatedFigure 5 Levels of serum antibodies. Anti-N antibodies were detected u
of 0.4 (A) and anti-GP2/GP5 antibodies were detected using the LIVTESTSU
greater than 20 as positive (B). Each point represents the mean (±S.D.) genimmunity. PRRSV infection alone can induce high levels
of IFN-γ as shown in this (Figure 4A) and previous studies
[24,28,29]. In the current study, piglets which received the
vaccination did not produce high levels of IFN-γ after HP-
PRRSV challenge (Groups 3 and 4 in Figure 4A), indicat-
ing that the CH-1R down-regulated IFN-γ expression
which was not affected by Mab2-5G2 or aAb2s (Group 1
and 2 in Figure 4A). The down-regulated IFN-γ expres-
sion by CH-1R and the high level of expression induced
by HP-PRRSV infection showed that the IFN-γ mediated
cell immune response were not capable of eliminating
HP-PRRSV. At present, the role of IFN-γ in the immune
response to CH-1R and HP-PRRSV infection is not clear
and warrants further investigation.sing the HerdCheck® PRRS ELISA kit with the cutoff value of S/P ratio
ISPRRS A/S® kit with the relative index (expressed as a percentage)
erated from six groups of piglets on different DPIs or DPCs.
Table 3 Neutralizing antibodies detected from sera
collected on different DPIs and DPCs
DPIs/
DPCs
Titers of neutralizing antibodies from six groups of piglets1
1 2 3 4 5 6
DPIs
0 0 (6) 2 0 (6) 0 (6) 0 (6) 0 (6) 0 (6)
7 0 (6) 0 (6) 0 (6) 0 (6) 0 (6) 0 (6)
14 0 (6) 0 (6) 0 (6) 0 (6) 0 (6) 0 (6)
21 2.3 (6) 2.7 (6) 0 (6) 0 (6) 0 (6) 0 (6)
28 3.3 (6) 3.3 (6) 0(6) 0 (6) 0 (6) 0 (6)
35 3.3 (6) 3.7 (6) 4.7 (6) 5.3 (6) 0 (6) 0 (6)
DPCs
0 3.7 (6) 3.7 (6) 6 (6) 6.3 (6) 0 (6) 0 (6)
3 2.7 (6) 3.3 (6) 5.3 (6) 5.3 (6) 0 (6) 0 (6)
7 3.3 (6) 3.3 (6) 5.3 (6) 6 (6) 0 (6) 0 (6)
10 3.3 (6) 3.3 (6) 6.7 (6) 8 (6) 0 (6) 0 (6)
14 3.7 (6) 4.7 (6) 8.7 (6) 10.1(6) 5.3 (6) 0 (6)
21 6 (2) 6.7 (3) 10.7 (3) 13.3 (3) 12 (2) 0 (3)
1Neutralizing antibodies were detected to evaluate the ability of antibodies
against Mab2-5G2 and aAb2s to neutralize PRRSV infection of Marc-145 cells.
Briefly, a 2-fold diluted serum sample and a titer of 100 TCID50/mL was
incubated for 1 h at 37°C and was transferred to a 96-well plate containing a
Marc-145 cell monolayer. Neutralizing antibody titers were defined as the
mean of reciprocal of the highest dilution of sera that inhibited 50% CPE.
2Each number represents the mean dilution of neutralizing antibody titers
generated from six groups of piglets on different DPIs/DPCs. The numbers in
parentheses were the numbers of piglets measured on different DPIs/DPCs.
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concentrations of serum IL-2 on 14 DPI and 0 DPC be-
fore HP-PRRSV challenge (Figure 4B). However, piglets
challenged with HP-PRRSV alone or who received CH-
1R did not produce IL-2, which is consistent with other
studies of PRRSV infection [19,30]. IL-2 is related to the
Th1 responses and used to evaluate candidate vaccines
to PRRSV and other viruses [17,31,32]. IL-2 is also ne-
cessary during T cell development in the thymus for the
maturation of regulatory T cells (T-regs). After exiting
from the thymus, T-regs prevent other T cells from
recognizing and reacting against “self antigens” [33,34].
At present, the role of IL-2 in PRRSV infection was un-
known. The poor health status of piglets in Group 1 and
2 who received Mab2-5G2 or aAb2s showed a high level
of IL-2 before and after HP-PRRSV challenge (Figure 4B)
and may have a negative effect on the immune responses
against HP-PRRSV infection.
IL-4 is a key regulator in humoral and adaptive im-
munity in association with the down-regulation of Th1
cell responses and promotion of Th2 cell development
[35]. In this study, changes of serum IL-4 concentrations
at different times corresponded to the difference of the
animals’ health status after HP-PRRSV challenge (Table 1,
Figures 2 and 3). These findings suggested that at the
beginning of the HP-PRRSV challenge, IL-4 down-regulates the inflammatory response and promotes
PRRSV replication (Figure 4, Table 2). This may have in-
creased the pathogenicity of PRRSV by down-regulating
cellular immunity and thus reduces the ability of the at-
tenuated vaccine to protect the pigs against PRRSV in-
fection. However, later after the HP-PRRSV challenge,
high serum concentrations of IL-4 are needed for the de-
velopment of the adaptive immunity against PRRSV infec-
tion, enhancement of the immune stages and production
of antibodies (Figure 4).
Functional studies on IL-10 suggest that it has im-
munosuppressive properties and can prevent the devel-
opment of Th1-mediated autoimmune diseases [36].
Some viruses, including PRRSV, can induce IL-10 pro-
duction to inhibit the host immune response and ham-
per the process of virus clearance [30,37-39]. In our
study, piglets challenged with HP-PRRSV alone devel-
oped high levels of IL-10 (Figure 4D), which indicated
that IL-10 also inhibits the cell-mediated immunity and
keeps the longer duration of viremia in HP-PRRSV
infection.
The animals that received control antibodies and CH-
1R produced higher levels of anti-GP2/GP5 antibodies
than those that received Mab2-5G2 or aAb2 (Figure 5B).
However, the time of onset and levels of neutralizing
antibodies produced in these animals were different
(Table 3) in which the piglets received Mab2-5G2 or
aAb2 produced neutralizing antibodies at early (21 DPI)
stage with low levels even after the HP-PRRSV challenge.
The presence of the low levels of neutralizing antibodies
(titer < 7, Table 3) before the HP-PRRSV challenge may
be responsible for the antibody-dependent enhancement
[40-42] leading to poor health status with pneumonia
and thymus atrophy (Table 1, Figure 2, Figure 3).
Conclusions
When the anti-idiotypic antibodies specific for anti-
PRRSV GP5 antibodies are present, the use of attenuated
PRRSV vaccine CH-1R against HP-PRRSV infection is
not recommended. It can result in the altered produc-
tion of cytokines, low levels of neutralizing antibodies
and the poor health status with pneumonia and thymus
atrophy.
Methods
PRRSV, vaccine and anti-Id
The PRRSV strain used in this study was HP-PRRSV
HuN4 strain (GenBank no. EF635006) [43]. The attenu-
ated PRRSV vaccine, CH-1R, was generated from CH-
1a, a North American type strain isolated from China
(GenBank no. EU807840) [24]. Monoclonal Abs were
Mab2-5G2 specific for anti-PRRSV GP5 antibody and a
control monoclonal Ab 7H12 specific for avian hepatitis
E virus [23,44]. The aAb2s specific for anti-PRRSVGP5
Yu et al. BMC Veterinary Research 2014, 10:39 Page 8 of 10
http://www.biomedcentral.com/1746-6148/10/39were purified from the sera of pigs experimentally in-
fected with HP-PRRSV HuN4 strain and normal swine
IgGs were prepared from PRRSV negative pigs [45].
Each of the Mabs and swine IgGs was mixed with 10%
(w/v) aluminum hydroxide adjuvant (Rehydragel, SEP-
PIC, France) on a magnetic stirrer (at 180 rpm) over-
night and stored at 4°C.
Animal study
Thirty-six 28-day-old PRRSV-free piglets were obtained
from a PRRS free farm and randomly divided into 6
groups (Table 4).
The animals were kept in 6 separate rooms, fed with
the commercial diets and water ad libitum throughout
the experiment. Sera were collected on 0, 7, 14, 21, 28,
35 DPI and 0, 3, 5, 7, 10, 14, 21 DPC and used for the
detection of viremia levels of cytokines and antibodies
against PRRSV N, GP2/GP5 antigens. The animal exper-
iments were reviewed and approved by Animal Care
Committee of Northwest A&F University. At each time
point of necropsy (described below) and at the end of
experiment, all animals were humanely euthanized.
Clinical evaluation
Piglets were monitored daily for clinical signs prior to feed-
ing, including anorexia, lethargy, fever, and emaciation.
The respiratory scores were given from 0 to 4 (0 - normal;
1 - tachypnea when stressed; 2 - tachypnea at rest; 3 -
tachypnea and dyspnea at rest; 4 - severe tachypnea and
dyspnea with labored and jerky breathing) [28].
Necropsy
Three piglets from each Group were euthanized on 14
DPC and the remaining three piglets from each group were
euthanized on 28 DPC. At necropsy, the macroscopic le-
sions of the thymus and lungs were recorded, including the
piglets died from PRRS during the experiment.
Histological examination
Sections of the thymus and lungs were prepared at nec-





0 Mab2-5G2 aAb2s 7H12
143 CH-1R CH-1R CH-1R
28 CH-1R CH-1R CH-1R
424 HP-PRRSV HP-PRRSV HP-PRRS
1The amount of IgG each piglet received was 100 μg/kg of body weight and PBS w
2The numbers were the days post injection (DPI). 42 DPI was also the 0 days post c
3On 14 DPI, the piglets received CH-1R, the attenuated PRRSV vaccine and generate
(GenBank no. EU807840) [24] i.m. on the left side of the neck at 2 doses/piglet dilu
4On 42 DPI, the piglets were challenged with HP-PRRSV HuN4 strain at 3 × 105 TCIDbuffered formalin and processed for histological examin-
ation using hematoxylin and eosin staining as described
previously [46].
Fluorescent quantitative RT-PCR
TaqMan fluorescent quantitative RT-PCR (qRT-PCR)
was performed as described previously [28] to detect
PRRSV in sera.
Detection of serum cytokines
Levels of serum IFN-γ, IL-2, IL-4 and IL-10 were deter-
mined using the commercial ELISA kits (Market Inc,
USA). The serum concentrations of cytokines (pg/ml)
were calculated according to the recombinant porcine
cytokines standards supplied in the kits.
Serology
Serum antibodies against PRRSV N and GP2/GP5 anti-
gens were detected using the HerdCheck® ELISA kit
(IDEXX Laboratories, Westbrook, Maine, U.S.A.) and
LIVTESTSUISPRRS A/S® kit (Laboratorios Hipra, Amer,
Girona, Spain), respectively. The S/P ratio of HerdCheck®
ELISA kit greater than 0.4 and a relative index (expressed
as a percentage, IRPC) of LIVTESTSUISPRRS A/S® kit
greater than 20 were considered positive.
Virus neutralization assays (VN) was performed as de-
scribed previously [47] to detect the neutralizing anti-
bodies with the following modifications. Briefly, a 2-fold
serial diluted serum samples were mixed with an equal
volume of HP-PRRSV HuN4 strain solution with a titer
of 100 TCID50/mL and incubated for 1 h at 37°C. The
mixture was transferred to a 96-well plate containing
Marc-145 cells. Cytopathic effect (CPE) was recorded for
7 days. The titers of neutralizing antibodies were defined
as the reciprocal of the highest dilution that inhibited
CPE in 50% of the inoculated wells.
Statistical analysis
The numerical data were expressed as mean ± S.D. Re-
spiratory scores, virus quantity and serum concentra-
tions of cytokines were analyzed using GraphPad Prismt time points1
piglets received injections1
4 5 6
normal swine IgG PBS PBS
CH-1R PBS PBS
CH-1R PBS PBS
V HP-PRRSV HP-PRRSV PBS
as 2 mls via intramuscularly (i.m.) injection.
hallenge (DPC).
d from CH-1a, a North American type strain isolated from China
ted in 2 ml of PBS.
50/piglet and also considered as 0 days post challenge (DPC).
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http://www.biomedcentral.com/1746-6148/10/39software (version 5.02 for Windows; GraphPad Software
Inc.) for variance (ANOVA). A p value less than 0.05
was considered statistically significant.
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